Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Else Nutrition Holdings ( (TSE:BABY) ) just unveiled an announcement.
Else Nutrition plans to relaunch its Canadian operations in early 2026, shifting from a third-party distributor to a direct-to-retail distribution model after a previous market entry in 2022 that delivered more than CAD$1 million in revenue in 2023 but later suffered from stock shortages and reduced marketing activity. The company has secured direct vendor status with Canada’s largest national retailer, is working to re-establish and expand relationships with other national and specialty retailers while boosting its e-commerce presence, and expects the relaunch to generate about CAD$500,000 in its first year and ultimately make Canada a core growth market contributing 10–15% of U.S. sales, supporting its broader strategy to improve margins and accelerate revenue growth from 2026 onward.
The most recent analyst rating on (TSE:BABY) stock is a Sell with a C$0.11 price target. To see the full list of analyst forecasts on Else Nutrition Holdings stock, see the TSE:BABY Stock Forecast page.
Spark’s Take on TSE:BABY Stock
According to Spark, TipRanks’ AI Analyst, TSE:BABY is a Underperform.
Else Nutrition Holdings Inc’s overall stock score is primarily impacted by its poor financial performance, characterized by declining revenues and severe profitability issues. Technical analysis further indicates bearish momentum, with the stock trading below key moving averages and nearing oversold conditions. The negative P/E ratio and lack of dividend yield also contribute to the low valuation score. These factors collectively result in a low overall stock score.
To see Spark’s full report on TSE:BABY stock, click here.
More about Else Nutrition Holdings
Else Nutrition Holdings Inc. is a food and nutrition company in an international expansion phase, specializing in innovative, clean, plant-based food and nutrition products for infants, toddlers, children and adults. Its flagship offering is a plant-based, non-soy, whole-food alternative to dairy-based infant and toddler formulas, which has gained national retailer support, strong online sales, and multiple industry awards, particularly in the baby and toddler nutrition segment.
Average Trading Volume: 92,122
Technical Sentiment Signal: Sell
Current Market Cap: C$3.93M
See more data about BABY stock on TipRanks’ Stock Analysis page.